✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
In this review, themechanisms that are suggested in ACE-I-induced cough pathophysiology will be discussed in detail in light of the current literature.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Angiotensin-converting enzyme inhibitors (ACE-I) are widely used in diseases, such as hypertension, congestive heart failure, and myocardial infarction.
📊
Key Findings & Data:Although these drugs are well tolerated, one out of five patients discontinues ACE-I due to drug side effects, mainlychronic cough.
💡
Conclusion & Impact:In this review, themechanisms that are suggested in ACE-I-induced cough pathophysiology will be discussed in detail in light of the current literature.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Özet
Angiotensin-converting enzyme inhibitors (ACE-I) are widely used in diseases, such as hypertension, congestive heart failure, and myocardial infarction. Although these drugs are well tolerated, one out of five patients discontinues ACE-I due to drug side effects, mainlychronic cough. However, the pathogenesis of ACE-I-induced cough remains controversial and requires further study. In this review, themechanisms that are suggested in ACE-I-induced cough pathophysiology will be discussed in detail in light of the current literature.
🔖
Cite This Article
YILMAZ, İ. (2019). Angiotensin-Converting Enzyme Inhibitors Induce Cough. Turkish Thoracic Journal, Cilt: 20 - Sayı: 1, 36–42. https://ajindex.com/articles/418012